Kiyatec
Pre-clinicalKiyatec is disrupting cancer care by accurately predicting patient–specific response and non–response before treatment begins.
Founded
2005
Focus
OncologyDiagnostics
About
Kiyatec is disrupting cancer care by accurately predicting patient–specific response and non–response before treatment begins.
Funding History
4Total raised: $26.5M
Grant$2MNational Cancer InstituteJun 15, 2022
Series B$15MLabCorpApr 15, 2021
Series A$8MLabCorpSep 15, 2018
Seed$1.5MUndisclosedJun 15, 2015
Company Info
TypePrivate
Founded2005
LocationGreenville, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile